Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 31376 - 31400 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Diazoxide	Approved Investigational	KCNJ11	3767	downregulated	Diazoxide results in decreased expression of KCNJ11 mRNA	11p15.1	A22200
Dichloroacetic acid	Approved Investigational Withdrawn	CXCR2	3579	upregulated	Dichloroacetic Acid results in increased expression of CXCR2 mRNA	2q35	A22201
Dichloroacetic acid	Approved Investigational Withdrawn	CXCR3	2833	upregulated	Dichloroacetic Acid results in increased expression of CXCR3 mRNA	Xq13.1	A22201
Cisplatin	Approved Investigational	AARS	16	downregulated	Cisplatin results in decreased expression of AARS mRNA	16q22.1	A20427
Cisplatin	Approved Investigational	ABCB1	5243	upregulated	Cisplatin results in increased expression of ABCB1 mRNA	7q21.12	A21239
Cisplatin	Approved Investigational	ABCB6	10058	downregulated	Cisplatin results in decreased expression of ABCB6 mRNA	2q35	A22202
Cisplatin	Approved Investigational	ABCB6	10058	upregulated	Cisplatin results in increased expression of ABCB6 mRNA	2q35	A20427
Cisplatin	Approved Investigational	ABCC2	1244	downregulated	Cisplatin results in decreased expression of ABCC2 mRNA	10q24.2	A22202
Cisplatin	Approved Investigational	ABCC3	8714	upregulated	Cisplatin results in increased expression of ABCC3 mRNA	17q21.33	A22202
Cisplatin	Approved Investigational	ABCG1	9619	downregulated	Cisplatin results in decreased expression of ABCG1 mRNA	21q22.3	A20427
Cisplatin	Approved Investigational	ABHD4	63874	upregulated	Cisplatin results in increased expression of ABHD4 mRNA	14q11.2	A22203 A20427
Cisplatin	Approved Investigational	ABR	29	downregulated	Cisplatin results in decreased expression of ABR mRNA	17p13.3	A22204
Cisplatin	Approved Investigational	ABTB2	25841	downregulated	Cisplatin results in decreased expression of ABTB2 mRNA	11p13	A22204
Cisplatin	Approved Investigational	ACACA	31	downregulated	Cisplatin results in decreased expression of ACACA mRNA	17q12	A22204 A22205
Cisplatin	Approved Investigational	ACACB	32	downregulated	Cisplatin results in decreased expression of ACACB mRNA	12q24.11	A22205
Cisplatin	Approved Investigational	ACSL1	2180	downregulated	Cisplatin results in decreased expression of ACSL1 mRNA	4q35.1	A20427
Cisplatin	Approved Investigational	ACVR1C	130399	upregulated	Cisplatin results in increased expression of ACVR1C mRNA	2q24.1	A22206
Cisplatin	Approved Investigational	ADK	132	downregulated	Cisplatin results in decreased expression of ADK mRNA	10q22.2	A22204
Cisplatin	Approved Investigational	ADRM1	11047	upregulated	Cisplatin results in increased expression of ADRM1 mRNA	20q13.33	A22207
Cisplatin	Approved Investigational	AGRN	375790	upregulated	Cisplatin results in increased expression of AGRN mRNA	1p36.33	A20427
Cisplatin	Approved Investigational	AIFM2	84883	downregulated	Cisplatin results in decreased expression of AIFM2 mRNA	10q22.1	A20427
Cisplatin	Approved Investigational	AK1	203	upregulated	Cisplatin results in increased expression of AK1 mRNA	9q34.11	A22204 A22203
Cisplatin	Approved Investigational	AK3	50808	upregulated	Cisplatin results in increased expression of AK3 mRNA	9p24.1	A20427
Cisplatin	Approved Investigational	AK4	205	upregulated	Cisplatin results in increased expression of AK4 mRNA	1p31.3	A20427
Cisplatin	Approved Investigational	AKAP13	11214	downregulated	Cisplatin results in decreased expression of AKAP13 mRNA	15q25.3	A22204

Displaying entries 31376 - 31400 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability